Return to Main Menu
|
AGA: sedation safe for endoscopic
procedures
The
use of an evidence-based sedation protocol for endoscopic
procedures improves the quality of practice and reduces the incidence
of sedation-related adverse events, according to a study co-authored by
MUSC’s Mark DeLegge, M.D., and published in the August issue of
Gastroenterology, the official journal of the American
Gastroenterological Association (AGA) Institute.
“The AGA Institute supports the administration of sedation by
gastroenterologists performing endo-scopic procedures on average risk
patients, provided that they have proper training and experience,” said
Nicholas LaRusso, M.D., president, AGA Institute. “Patients should feel
comfortable undergoing an endoscopic procedure, including the
administration of intravenous sedation, by a gastroenterologist who is
trained and licensed.”
The use of sedation during endoscopic procedures, including
colonoscopies and upper endoscopies, is considered a medical necessity
by gastroenterologists, with more than 98 percent utilizing sedation
during these procedures. By reducing a patient’s anxiety and discomfort
during the procedure, gastroenterologists are able to better ensure
that they are performing a thorough exam while minimizing the patient’s
risk of injury and improving their tolerability, according to the study
titled AGA Institute Review of Endoscopic Sedation.
“Due to the widespread use of sedation during endoscopy procedures, it
is of great importance that gastro-enterologists implement sedation
protocols in their practices to improve the quality of practice and
minimize the risk of sedation-related adverse events,” said Lawrence
Cohen, M.D., associate clinical professor at The Mount Sinai Hospital,
New York, and co-author of the paper.
But DeLegge urges continued review of methods used for sedation to
assure their safety.
“Efforts are ongoing to improve endoscopic sedation, including the
evaluation of new drugs and the re-assessment of current agents, as
well as the development of new methods of delivery,” said Delegge,
director, Digestive Disease Center and Section of Nutrition; and
professor of medicine. “While there are several promising prospects on
the horizon, we must make every effort to ensure that our procedures
are safe and well tolerated with the agents that are currently
available to us.”
The review was based on an evidence-based analysis of the literature,
whenever possible. In areas in which evidence from controlled studies
was absent, data from case series, retrospective database studies and
expert opinions in endoscopy and anesthesia were used.
The AGA Institute Review generated 16 summary statements and
recommen-dations on the use of sedation in endoscopies. A few of them
were:
- Pre-procedure patient evaluations should be performed and
documented prior to endoscopy procedures to enable gastroenterologists
to identify pertinent patient history and physical findings that may
affect sedation outcomes.
- Use of an anesthesia professional should be considered
during endoscopy procedures including patients with patients with
severe systemic disease or patients who are morbid or at substantial
risk of death, and patients with a history of being difficult to sedate
- Endoscopists should be familiar with the unique
pharmacologic properties of all agents used for sedation and reversal
during the procedures, including time of onset, peak response, duration
of effect, patient variations in responsiveness to the drugs and
potential drug-drug interactions.
- Medical professionals who administer sedation should
possess the ability to recognize and rescue patients who fall into a
level of sedation deeper than originally intended.
- New methods of monitoring are currently undergoing clinical
evalua-tion. Their routine use for moderate sedation cannot be
recommended currently based upon the available literature. These
methods include capnography, a noninvasive technique to measure CO2 in
expired gases, and a noninvasive method of assessing a patient’s level
of consciousness.
- Endoscopists’ training for sedation should emphasize an
understanding of medications used for endoscopic sedation and the
skills necessary for the diagnosis and treatment of cardio-pulmonary
complication as well as current certification in advanced cardiac life
support (ACLS).
Friday, Aug. 10, 2007
Catalyst Online is published weekly,
updated
as needed and improved from time to time by the MUSC Office of Public
Relations
for the faculty, employees and students of the Medical University of
South
Carolina. Catalyst Online editor, Kim Draughn, can be reached at
792-4107
or by email, catalyst@musc.edu. Editorial copy can be submitted to
Catalyst
Online and to The Catalyst in print by fax, 792-6723, or by email to
catalyst@musc.edu. To place an ad in The Catalyst hardcopy, call Island
Publications at 849-1778, ext. 201.
|